• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Annual Changes to the Nasdaq-100 Index®

    12/13/24 8:00:00 PM ET
    $AXON
    $ILMN
    $MRNA
    $MSTR
    Ordnance And Accessories
    Industrials
    Medical Specialities
    Health Care
    Get the next $AXON alert in real time by email

    NEW YORK, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced the results of the annual reconstitution of the Nasdaq-100 Index® (NASDAQ:NDX), which will become effective prior to market open on Monday, December 23, 2024.

    The following three companies will be added to the Index: Palantir Technologies Inc. (NASDAQ:PLTR), MicroStrategy Incorporated (NASDAQ:MSTR), and Axon Enterprise, Inc. (NASDAQ:AXON).

    The Nasdaq-100 Index® is composed of 100 of the largest non-financial companies1 listed on The Nasdaq Stock Market® and dates to January 1985 – nearly 40 years ago –when it was launched along with the Nasdaq Financial-100™ Index, which is comprised of 100 of the largest financial stocks on Nasdaq® These indexes act as benchmarks for financial products such as options, futures, and funds. The Nasdaq-100® is reconstituted each year in December, timed to coincide with the quadruple witch expiration Friday of the quarter.

    The Nasdaq-100 Index® is the basis of the Invesco QQQ Trust (NASDAQ:QQQ) which aims to provide investment results that, before expenses, correspond with the Nasdaq-100 Index® performance. In addition, options, futures and structured products based on the Nasdaq-100 Index® and the Invesco QQQ Trust trade on various exchanges.

    As a result of the reconstitution, the following three companies will be removed from the Index: Illumina, Inc. (NASDAQ:ILMN), Super Micro Computer, Inc. (NASDAQ:SMCI), and Moderna, Inc. (NASDAQ:MRNA).

    Information

    For information about the three companies to be added to the Nasdaq-100 Index®, please visit the following respective company websites:

    Palantir Technologies Inc. – https://www.palantir.com/

    MicroStrategy Incorporated – https://www.microstrategy.com/

    Axon Enterprise, Inc. – https://www.axon.com/

    About Nasdaq Global Indexes

    Nasdaq Global Indexes has been creating innovative, market-leading, transparent indexes since 1971. Today, our index offering spans geographies and asset classes and includes diverse. We continuously offer new opportunities for financial product sponsors across a wide spectrum of investable products and for asset managers to measure risk and performance. Nasdaq also provides exchange listing, custom index, and design solutions to financial organizations worldwide.

    _______________

    1 As outlined in the Nasdaq-100 Index® Methodology

    About Nasdaq

    Nasdaq (NASDAQ:NDAQ) is a leading global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and interact with the global capital markets and the broader financial system. We aspire to deliver world-leading platforms that improve the liquidity, transparency, and integrity of the global economy. Our diverse offering of data, analytics, software, exchange capabilities, and client-centric services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions, and career opportunities, visit us on LinkedIn, on X, or at www.nasdaq.com. 

    The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular financial product or an overall investment strategy. Neither The Nasdaq OMX Group, Inc. nor any of its affiliates makes any recommendation to buy or sell any financial product or any representation about the financial condition of any company or fund. Statements regarding Nasdaq's proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.

    - NDAQG - 

    Media Relations Contact Investor Relations Contact 
    Name: Jennifer Lawson

    Email: [email protected]

     Name: Index Client Services

    Email: [email protected]

     
        


    Primary Logo

    Get the next $AXON alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AXON
    $ILMN
    $MRNA
    $MSTR

    CompanyDatePrice TargetRatingAnalyst
    Illumina Inc.
    $ILMN
    8/12/2025$94.00Outperform → Neutral
    Daiwa Securities
    Axon Enterprise Inc.
    $AXON
    8/5/2025$900.00Hold → Buy
    Craig Hallum
    Palantir Technologies Inc.
    $PLTR
    8/5/2025$160.00Sell → Hold
    Deutsche Bank
    Palantir Technologies Inc.
    $PLTR
    7/25/2025$170.00Overweight
    Piper Sandler
    Nasdaq Inc.
    $NDAQ
    7/25/2025$115.00Neutral → Buy
    UBS
    Axon Enterprise Inc.
    $AXON
    7/16/2025$820.00Neutral
    UBS
    Palantir Technologies Inc.
    $PLTR
    7/16/2025$135.00Underperform → Neutral
    Mizuho
    Strategy Inc
    $MSTR
    7/15/2025$175.00 → $200.00Sell
    Monness Crespi & Hardt
    More analyst ratings

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    BioStem Technologies Appoints Brandon Poe as Chief Financial Officer

    POMPANO BEACH, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. ("BioStem" or the "Company") (OTC:BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today announced the appointment of Brandon Poe as its Chief Financial Officer (CFO). Mr. Poe has served on BioStem's Board of Directors since 2022. Michael Fortunato, the Company's prior CFO, has assumed the role of Chief Accounting Officer. "I'm excited to welcome Brandon as CFO during this pivotal period of growth and innovation for BioStem," said Jason Matuszewski, Chairman and CEO. "Brandon brings proven financial leader

    8/14/25 4:01:44 PM ET
    $ILMN
    Medical Specialities
    Health Care

    Strategy Announces Legal Name Change from MicroStrategy Incorporated to Strategy Inc

    In furtherance of the re-brand announced on February 5, 2025, Strategy Inc (NASDAQ:MSTR), the largest corporate holder of bitcoin and the world's first Bitcoin Treasury Company, today announced it has changed its legal name from MicroStrategy Incorporated to "Strategy Inc", effective August 11, 2025. The Company's securities listed on the Nasdaq Global Select Market continue to trade under their ticker symbols: MSTR (Class A common stock), STRK (8.00% Series A Perpetual Strike Preferred Stock), STRF (10.00% Series A Perpetual Strife Preferred Stock), STRD (10.00% Series A Perpetual Stride Preferred Stock), and STRC (Variable Rate Series A Perpetual Stretch Preferred Stock). CUSIP numbers al

    8/14/25 9:00:00 AM ET
    $MSTR
    $STRC
    Computer Software: Prepackaged Software
    Technology
    Wholesale Distributors
    Industrials

    Palantir and SOMPO Expand Partnership in Multi-Year Agreement

    Palantir Technologies Inc. (NASDAQ:PLTR), a leading provider of enterprise operating systems, today announced a multi-year expansion of their partnership with SOMPO Holdings, Inc. via its Japanese joint venture Palantir Technologies Japan KK. SOMPO utilizes Palantir's Foundry across several of their subsidiaries with thousands of daily users. Since 2020, SOMPO has been using Foundry across care facilities in Japan to support the care of senior citizens, report care to the government, and raise the urgent needs of patients. More recently, SOMPO Japan is using Foundry as it revamps its claims process end to end. Foundry is deeply embedded at every stage across key decisions - from fraud det

    8/12/25 6:59:00 AM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    $AXON
    $ILMN
    $MRNA
    $MSTR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    November 30, 2020 - Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Second COVID-19 Vaccine Candidate

    For Immediate Release: November 30, 2020 The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 17 to discuss the request for emergency use authorization (EUA) for a COVID-19 vaccine from Moderna, Inc. “In keeping with the FDA’s commitment to ensuring full transparency, dialogue and efficiency, the Vaccines and Related Biological Products Advisory Comm

    11/30/20 5:12:14 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Illumina downgraded by Daiwa Securities with a new price target

    Daiwa Securities downgraded Illumina from Outperform to Neutral and set a new price target of $94.00

    8/12/25 7:55:50 AM ET
    $ILMN
    Medical Specialities
    Health Care

    Axon upgraded by Craig Hallum with a new price target

    Craig Hallum upgraded Axon from Hold to Buy and set a new price target of $900.00

    8/5/25 7:30:21 AM ET
    $AXON
    Ordnance And Accessories
    Industrials

    Palantir Technologies upgraded by Deutsche Bank with a new price target

    Deutsche Bank upgraded Palantir Technologies from Sell to Hold and set a new price target of $160.00

    8/5/25 7:04:41 AM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    COO & CFO Bagley Brittany covered exercise/tax liability with 815 shares, decreasing direct ownership by 0.71% to 113,892 units (SEC Form 4)

    4 - AXON ENTERPRISE, INC. (0001069183) (Issuer)

    8/15/25 4:50:09 PM ET
    $AXON
    Ordnance And Accessories
    Industrials

    CPO & CTO Kunins Jeffrey C covered exercise/tax liability with 5,122 shares and sold $5,919,011 worth of shares (7,891 units at $750.10), decreasing direct ownership by 8% to 144,538 units (SEC Form 4)

    4 - AXON ENTERPRISE, INC. (0001069183) (Issuer)

    8/15/25 4:46:19 PM ET
    $AXON
    Ordnance And Accessories
    Industrials

    PRESIDENT Isner Joshua covered exercise/tax liability with 11,937 shares and sold $11,879,725 worth of shares (15,919 units at $746.26), decreasing direct ownership by 10% to 238,379 units (SEC Form 4)

    4 - AXON ENTERPRISE, INC. (0001069183) (Issuer)

    8/15/25 4:40:29 PM ET
    $AXON
    Ordnance And Accessories
    Industrials

    $AXON
    $ILMN
    $MRNA
    $MSTR
    SEC Filings

    View All

    SEC Form DEF 14A filed by Invesco QQQ Trust, Series 1

    DEF 14A - INVESCO QQQ TRUST, SERIES 1 (0001067839) (Filer)

    8/18/25 12:40:35 PM ET
    $QQQ

    SEC Form 13F-HR filed by Axon Enterprise Inc.

    13F-HR - AXON ENTERPRISE, INC. (0001069183) (Filer)

    8/14/25 11:10:07 AM ET
    $AXON
    Ordnance And Accessories
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by Nasdaq Inc.

    SCHEDULE 13G/A - NASDAQ, INC. (0001120193) (Subject)

    8/12/25 10:34:26 AM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Partovi Hadi bought $1,004,920 worth of shares (1,358 units at $740.00), increasing direct ownership by 0.57% to 237,938 units (SEC Form 4)

    4 - AXON ENTERPRISE, INC. (0001069183) (Issuer)

    8/15/25 4:36:59 PM ET
    $AXON
    Ordnance And Accessories
    Industrials

    Director Briger Peter L Jr bought $19,800,000 worth of Series A Perpetual Stretch Preferred Stock (220,000 units at $90.00) (SEC Form 4)

    4 - MICROSTRATEGY Inc (0001050446) (Issuer)

    7/29/25 6:20:52 PM ET
    $MSTR
    Computer Software: Prepackaged Software
    Technology

    President & CEO Le Phong bought $495,000 worth of Series A Perpetual Stretch Preferred Stock (5,500 units at $90.00) (SEC Form 4)

    4 - MICROSTRATEGY Inc (0001050446) (Issuer)

    7/29/25 4:55:28 PM ET
    $MSTR
    Computer Software: Prepackaged Software
    Technology

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Leadership Updates

    Live Leadership Updates

    View All

    BioStem Technologies Appoints Brandon Poe as Chief Financial Officer

    POMPANO BEACH, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. ("BioStem" or the "Company") (OTC:BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today announced the appointment of Brandon Poe as its Chief Financial Officer (CFO). Mr. Poe has served on BioStem's Board of Directors since 2022. Michael Fortunato, the Company's prior CFO, has assumed the role of Chief Accounting Officer. "I'm excited to welcome Brandon as CFO during this pivotal period of growth and innovation for BioStem," said Jason Matuszewski, Chairman and CEO. "Brandon brings proven financial leader

    8/14/25 4:01:44 PM ET
    $ILMN
    Medical Specialities
    Health Care

    Ajit Singh Appointed CEO of Harbinger Health and CEO-Partner of Flagship Pioneering

    Stephen Hahn to Transition to CEO Emeritus and Special Advisor and remain on Harbinger's board CAMBRIDGE, Mass., Aug. 11, 2025 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, and Harbinger Health, a biotechnology company pioneering the detection of early cancer, today announced the appointment of Ajit Singh, Ph.D. as CEO-Partner of Flagship and the new CEO of Harbinger.  Dr. Singh, a veteran of the diagnostics industry, will also continue as a Harbinger board member, a role he has held since 2024. Dr. Singh succeeds Stephen Hahn, M.D., who will transition from his role as CEO and remain closely involved with the company as CEO Emeritus and Special Advisor. He will co

    8/11/25 12:00:00 PM ET
    $FHTX
    $MRNA
    $SANA
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)

    Thomson Reuters Corp to Join the Nasdaq-100 Index® Beginning July 28, 2025

    NEW YORK, July 18, 2025 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced that Thomson Reuters Corp (NASDAQ:TRI), will become a component of the Nasdaq-100 Index® (NASDAQ:NDX®) and the Nasdaq-100 Equal Weighted™ Index (NASDAQ:NDXE) prior to market open on Monday, July 28, 2025. Thomson Reuters Corp will replace ANSYS, Inc. (NASDAQ:ANSS) in the Nasdaq-100 Index® and the Nasdaq-100 Equal Weighted™ Index. ANSYS, Inc. will also be removed from the Nasdaq-100 Tech Sector™ Index (NASDAQ:NDXT), the Nasdaq-100 Technology Sector Market-Cap Weighted™ Index (NDXTMC™), the Nasdaq-100 Technology Sector Adjusted Market-Cap Weighted™ Index (NDXT10™), the Nasdaq-100 ESG™ Index (NASDAQ:ND

    7/18/25 8:00:00 PM ET
    $ANSS
    $NDAQ
    $TRI
    Computer Software: Prepackaged Software
    Technology
    Investment Bankers/Brokers/Service
    Finance

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Financials

    Live finance-specific insights

    View All

    Supermicro Announces Fourth Quarter and Full Fiscal Year 2025 Financial Results

    Super Micro Computer, Inc. (NASDAQ:SMCI) ("Supermicro" or the "Company"), a Total IT Solution Provider for AI, Cloud, Storage, and 5G/Edge, today announced unaudited financial results for its fourth quarter and full fiscal year ended June 30, 2025. Fourth Quarter Fiscal Year 2025 Highlights Net sales of $5.8 billion versus $4.6 billion in Q3'25 and $5.4 billion in Q4'24. Gross margin of 9.5% versus 9.6% in Q3'25 and 10.2% in Q4'24. Net income of $195 million versus $109 million in Q3'25 and $297 million in Q4'24. Diluted net income per common share of $0.31 versus $0.17 in Q3'25 and $0.46 in Q4'24. Non-GAAP diluted net income per common share of $0.41 versus $0.31 in Q3

    8/5/25 4:05:00 PM ET
    $SMCI
    Computer Manufacturing
    Technology

    Axon reports Q2 2025 revenue of $669 million, up 33% year over year

    SCOTTSDALE, Ariz., Aug. 4, 2025 /PRNewswire/ -- Software & Services revenue grows 39% to $292 millionAnnual recurring revenue grows 39% to $1.2 billionNet income of $36 million supports non-GAAP net income of $174 million and Adjusted EBITDA of $172 millionRaises full year revenue outlook to a range of $2.65 billion to $2.73 billion, up from $2.60 billion to $2.70 billion.Fellow shareholders, Axon closed the first half of 2025 with record quarterly revenue, reflecting consistent execution and a strong foundation for long-term growth. Second quarter revenue grew 33% year over y

    8/4/25 4:01:00 PM ET
    $AXON
    Ordnance And Accessories
    Industrials

    Strategy Announces $4.2 Billion STRC At-The-Market Program

    Strategy™ (NASDAQ:MSTR, STRK, STRF, STRD, STRC)) today announced that it has entered into a sales agreement pursuant to which Strategy may issue and sell shares of its Variable Rate Series A Perpetual Stretch Preferred Stock, $0.001 par value per share (the "STRC Stock"), having an aggregate offering price of up to $4.2 billion (the "ATM Program"). Strategy expects to make sales of STRC Stock pursuant to the ATM Program in a disciplined manner over an extended period, taking into account the trading price and trading volumes of the STRC Stock at the time of sale. Strategy intends to use the net proceeds from the ATM Program for general corporate purposes, including the acquisition of bi

    7/31/25 4:20:00 PM ET
    $MSTR
    $STRC
    Computer Software: Prepackaged Software
    Technology
    Wholesale Distributors
    Industrials

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Illumina Inc.

    SC 13G/A - ILLUMINA, INC. (0001110803) (Subject)

    12/6/24 10:11:24 AM ET
    $ILMN
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Illumina Inc.

    SC 13G - ILLUMINA, INC. (0001110803) (Subject)

    12/5/24 7:27:01 PM ET
    $ILMN
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by MicroStrategy Incorporated

    SC 13G - MICROSTRATEGY Inc (0001050446) (Subject)

    11/14/24 6:24:12 PM ET
    $MSTR
    Computer Software: Prepackaged Software
    Technology